GandeviaB.Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J1975:51(7 Suppl):13–20.
2.
FreedmanT.Medihaler therapy for bronchial asthma: a new type of aerosol therapy. Postgrad Med1956:20:667–673.
3.
Conference on the scientific basis of respiratory therapy. Final reports: summaries and recommendations. Aerosol therapy. Am Rev Respir Dis1974;110(6 Pt 2):7–9.
4.
NewmanSP, MorénF, PaviaD, LittleF, ClarkeSW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis1981;124(3):317–320.
5.
TobinMJ, JenouriG, DantaI, KimC, WatsonH, SacknerMA. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis1982;126(4):670–675.
6.
DolovichM, RuffinR, CorrD, NewhouseMT. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest1983;84(1):36–41.
7.
BorgströmL.Local versus total systemic bioavailability as a means to compare different inhaled formulations of the same substance. J Aerosol Med1998;11(1):55–63.
